Skip to Content

135 (Nimodipine 30 mg)

Pill with imprint 135 is Yellow, Capsule-shape and has been identified as Nimodipine 30 mg. It is supplied by Caraco Pharmaceutical Laboratories.

Nimodipine is used in the treatment of subarachnoid hemorrhage and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nimodipine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 135

Nimodipine 30 mg 135

Nimodipine

Imprint
135
Strength
30 mg
Color
Yellow
Size
20.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Calcium channel blocking agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Caraco Pharmaceutical Laboratories
National Drug Code (NDC)
57664-0135
Inactive Ingredients
glycerin, peppermint oil, water, polyethylene glycol, gelatin, D&C Yellow No. 10, titanium dioxide, ammonia, ferrosoferric oxide, butyl alcohol, isopropyl alcohol, shellac, alcohol, propylene glycol, medium-chain triglycerides

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "135"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.